Registration:Sorry, public registration for this event has been closed.
Come network with 200+ life science representative's at NCBIO's Annual Membership Meeting. The program is built around the emergence of big data, health informatics, and precision innovation as the next major wave in life science development. The program features three keynote speakers and two panel discussions (not listed in program order).
State of the Industry (focus on big data)
W. Richard Staub III, President, Research & Development Solutions, Global Business Unit, IQVIA
Future of the BioPharma Industry
Paul Rudick, Gene Therapy Commercial Development Lead, Hemophilia, Pfizer Rare Disease, Pfizer
FDA Policies & Perspectives
Anna Abram, Deputy Commissioner for Policy, Planning, Legislation and Analysis, FDA
The Big Data Ecosystem & Its Uses
Brian Brazeau, Vice President of Biofuels, North America, Novozymes
Deborah Fisher, MD, Associate Director, Gastroenterology Group, Duke Clinical Research Institute
Gaurav Kaushik, Ph.D., Associate Director, Data Products and Strategy, Foundation Medicine